Prostate Cancer Clinical Decision Making by Diagnosed and High Risk Latino Men

确诊和高危拉丁裔男性的前列腺癌临床决策

基本信息

批准号：
7693849
负责人：
SALLY L Maliski
金额：
$ 23.1万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-09-26 至 2011-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7693849
关键词：
Accounting Acculturation Address Attention Attitude Belief Brothers California Caucasians Caucasoid Race Cause of Death Clinical Consensus Country Data Decision Making Development Diagnosis Disadvantaged Disclosure Disease Early treatment Education Face Feeling First Degree Relative Foundations Future Healthcare Hispanics Immigrant Individual Intervention Interview Knowledge Language Latino Life Literature Low income Malignant neoplasm of prostate Medical Methods Mexican Mexican Americans Minority Modeling Perception Population Process Public Health Reporting Research Review Literature Risk Role Screening for Prostate Cancer Screening procedure Second Primary Cancers Son Source Staging Treatment outcome Uncertainty Uninsured United States Variant Writing cancer therapy coping evidence base experience high risk high risk men men men&apos s group mortality public health relevance risk perception social disparities

项目摘要

DESCRIPTION (provided by applicant): Prostate cancer is the most common noncutaneous cancer and second leading cause of death among men in the United States, and Latinos are the fastest growing minority in the United States. However, low income Latino men are more likely to be uninsured, have less education, and have lower incomes. Many do not speak English as their first language. For these men, much of the available information to help with informed decision-making is not accessible. Because of the lack of consensus on the benefits of screening on prostate cancer mortality or of superior survival benefit of any one treatment for early stage prostate cancer, men are faced with life-altering decisions regarding screening and treatment for those who are diagnosed. Furthermore, men with a first degree relative with prostate cancer are at increased risk. Yet, how the rapidly growing population of Latino men approaches the decision-making process in prostate cancer is virtually unknown. Therefore, the overall purpose of this study is to develop descriptive models of prostate cancer screening, treatment, and diagnosis disclosure decision-making from the perspective of Latino men to form an evidence base for the development of culturally appropriate intervention strategies to facilitate informed and confident decision-making. Specifically, we aim to: 1. Describe the process of deciding on treatment and disclosing diagnosis from the perspective of Latino men who have been treated for prostate cancer and 2. Describe the process of deciding to be screened or not screened for prostate cancer by brothers or sons of Latino men diagnosed with prostate cancer. We will use qualitative descriptive methods to understand prostate cancer treatment, disclosure, and screening decision-making processes from the perspective of Latino men. Both specific aims will be addressed with in-depth individual interviews exploring involvement in and comfort with treatment decision making process, influences on the decision, and disclosure of diagnosis by treated men. For high risk men we will explore risk perception, knowledge and beliefs about prostate cancer screening, sources of information, facilitators and barriers, and decision implementation. Analyses will result in clear, in-depth descriptions that will guide the future development of intervention strategies to facilitate informed decision-making regarding prostate cancer treatment, disclosure, and screening among Latino men facing prostate cancer decisions. PUBLIC HEALTH RELEVANCE: The relevance of this study to public health lies in the fact that Latinos are the fastest growing minority in the United States and Mexican/Mexican-Americans make up over 70% of this growing Latino population. Understanding how treatment, disclosure, and screening decisions are made by Mexican/Mexican-American men from this research will lay the foundation for culturally relevant interventions to assist these men as they face life-altering decisions. Potentially, informed, confident decision-making participation may contribute to better treatment outcomes and appropriate screening for this disadvantaged group of men.

描述（由申请人提供）：前列腺癌是美国男性中最常见的非直率癌症和第二大死亡原因，而拉丁美洲人是美国增长最快的少数群体。但是，低收入的拉丁裔男性更有可能没有保险，受教育程度较低，收入较低。许多人不会说英语作为他们的母语。对于这些男人来说，无法访问许多可用的信息来帮助明智的决策。由于缺乏对筛查前列腺癌死亡率的益处或任何一种治疗方法对早期前列腺癌的益处的好处，因此男性面临着针对被诊断的人进行筛查和治疗的改变生活的决定。此外，患有前列腺癌的一级亲戚的男性风险增加。然而，实际上增长的拉丁裔男性人口如何处理前列腺癌的决策过程实际上是未知。因此，这项研究的总体目的是从拉丁裔男性的角度开发前列腺癌筛查，治疗和诊断披露决策制定的描述性模型，以构成发展文化适当的干预策略的证据基础，以促进知情和自信的决策。具体而言，我们的目的是：1。描述从已接受前列腺癌治疗的拉丁裔男性的角度来确定治疗和诊断的过程，2。描述确定被诊断为前列腺癌的兄弟或儿子筛查或未筛查前列腺癌的过程。我们将使用定性描述性方法从拉丁裔男人的角度了解前列腺癌的治疗，披露和筛查决策过程。这两个具体目标都将通过深入的个人访谈来解决，以探索参与和舒适治疗决策过程，对决策的影响以及治疗男性诊断的披露。对于高风险男人，我们将探讨有关前列腺癌筛查，信息来源，促进者和障碍以及决策实施的风险感知，知识和信念。分析将导致清晰，深入的描述，以指导未来的干预策略发展，以促进有关前列腺癌治疗，披露和面对前列腺癌决策的拉丁裔男性筛查的明智的决策。公共卫生相关性：这项研究与公共卫生的相关性在于，拉丁美洲人是美国增长最快的少数群体，墨西哥/墨西哥裔美国人占该拉丁裔人口增长的70％以上。了解这项研究的墨西哥/墨西哥裔美国人如何做出治疗，披露和筛查决定是如何为文化相关的干预措施奠定基础，以帮助这些人面临改变生活的决定。潜在的，知情，自信的决策参与可能有助于对这一处境不利的男性进行更好的治疗结果和适当的筛查。